For research and educational purposes only. Not medical advice.
GSK2881078 Reference
Educational, not medical advice reference for GSK2881078: SARM, Recovery; regulatory status, evidence posture, source review, and schedule notes. Also known…
Reference summary
Human studies in healthy older adults and COPD-associated muscle weakness reported lean-mass or endocrine signals, but did not establish a validated body-composition or athletic-performance indication.
- Categories
- SARM, Recovery
- Aliases
- GSK-2881078, Non-steroidal SARM, GSK SARM
- Evidence posture
- human — Clinical-development SARM, not an approved drug. Published human work is disease- or aging-context research, not a gym-use program. Liver-enzyme and HDL changes have been reported. WADA-prohibited under category S1.2 at all times.
- Regulatory status
- No FDA-approved GSK2881078 drug label. FDA consumer warnings against SARMs sold in bodybuilding products apply to the class. WADA prohibits SARMs under category S1.2 anabolic agents at all times.
- Content review status
- research reference
Selected public sources
- FDA consumer update: SARMs are not FDA-approved and cannot be legally marketed as dietary supplements
- WADA prohibited list: SARMs are category S1.2 anabolic agents prohibited at all times
- PubMed: GSK2881078 lean-mass study in healthy older men and women
- PubMed: GSK2881078 randomized trial in COPD muscle weakness
- PubMed: GSK2881078 equine metabolism study for doping control